Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |